Worcester, MA, United States of America

Gloria Y LoSchiavo


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gloria Y LoSchiavo: Innovator in Immunology and Oncology

Introduction: Gloria Y LoSchiavo is an accomplished inventor based in Worcester, MA, specializing in the development of unique pharmacological compounds. With a focus on addressing critical immunological and oncological conditions, her innovative work is paving the way for advancements in the medical field.

Latest Patents: Gloria holds a patent for "Indazolones as modulators of TNF signaling." This patent discloses a range of indazolone compounds, including pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers, and isomers. The significant potential of these compounds lies in their application for treating various immunological and oncological disorders, marking a promising development in therapeutic strategies.

Career Highlights: Gloria is affiliated with AbbVie Inc., a leading biopharmaceutical company known for its commitment to innovation and improving patient outcomes. Her work at AbbVie demonstrates her dedication to scientific research and the pursuit of breakthroughs in medicine.

Collaborations: Throughout her career, Gloria has collaborated with notable professionals, including coworkers Maria A Argiriadi and Eric C Breinlinger. Their collective expertise enhances the research environment and fosters innovative solutions in the realm of pharmaceuticals.

Conclusion: Gloria Y LoSchiavo's contributions to the field of immunology and oncology through her patent work exemplify the vital role of inventors in advancing medical science. As she continues to innovate, her efforts not only aim to address existing health challenges but also inspire future generations of scientists and inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…